002800 — Sinsin Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapContrarian

Annual balance sheet for Sinsin Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	799	2,240	346	540	3,876
Net Total Accounts Receivable
Net Total Receivables	24,890	27,724	30,191	32,833	34,869
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	36,467	45,048	47,108	51,492	59,420
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	69,345	66,825	68,264	65,718	64,020
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	114,307	121,213	124,409	129,484	137,497
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	33,919	42,327	51,720	59,101	60,363
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	59,381	61,515	62,114	63,610	62,668
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	54,927	59,698	62,295	65,874	74,829
Total Liabilities & Shareholders' Equity	114,307	121,213	124,409	129,484	137,497
Total Common Shares Outstanding